Cargando…

Improving Self-Care in Patients With Coexisting Type 2 Diabetes and Hypertension by Technological Surrogate Nursing: Randomized Controlled Trial

BACKGROUND: Technological surrogate nursing (TSN) derives from the idea that nurse-caregiver substitutes can be created by technology to support chronic disease self-care. OBJECTIVE: This paper begins by arguing that TSN is a useful and viable approach to chronic disease self-care. The analysis then...

Descripción completa

Detalles Bibliográficos
Autores principales: Or, Calvin Kalun, Liu, Kaifeng, So, Mike K P, Cheung, Bernard, Yam, Loretta Y C, Tiwari, Agnes, Lau, Yuen Fun Emmy, Lau, Tracy, Hui, Pui Sze Grace, Cheng, Hop Chun, Tan, Joseph, Cheung, Michael Tow
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148548/
https://www.ncbi.nlm.nih.gov/pubmed/32217498
http://dx.doi.org/10.2196/16769
_version_ 1783520618217472000
author Or, Calvin Kalun
Liu, Kaifeng
So, Mike K P
Cheung, Bernard
Yam, Loretta Y C
Tiwari, Agnes
Lau, Yuen Fun Emmy
Lau, Tracy
Hui, Pui Sze Grace
Cheng, Hop Chun
Tan, Joseph
Cheung, Michael Tow
author_facet Or, Calvin Kalun
Liu, Kaifeng
So, Mike K P
Cheung, Bernard
Yam, Loretta Y C
Tiwari, Agnes
Lau, Yuen Fun Emmy
Lau, Tracy
Hui, Pui Sze Grace
Cheng, Hop Chun
Tan, Joseph
Cheung, Michael Tow
author_sort Or, Calvin Kalun
collection PubMed
description BACKGROUND: Technological surrogate nursing (TSN) derives from the idea that nurse-caregiver substitutes can be created by technology to support chronic disease self-care. OBJECTIVE: This paper begins by arguing that TSN is a useful and viable approach to chronic disease self-care. The analysis then focuses on the empirical research question of testing and demonstrating the effectiveness and safety of prototype TSN supplied to patients with the typical complex chronic disease of coexisting type 2 diabetes and hypertension. At the policy level, it is shown that the data allow for a calibration of TSN technology augmentation, which can be readily applied to health care management. METHODS: A 24-week, parallel-group, randomized controlled trial (RCT) was designed and implemented among diabetic and hypertensive outpatients in two Hong Kong public hospitals. Participants were randomly assigned to an intervention group, supplied with a tablet-based TSN app prototype, or to a conventional self-managing control group. Primary indices—hemoglobin A(1c), systolic blood pressure, and diastolic blood pressure—and secondary indices were measured at baseline and at 8, 12, 16, and 24 weeks after initiation, after which the data were applied to test TSN effectiveness and safety. RESULTS: A total of 299 participating patients were randomized to the intervention group (n=151) or the control group (n=148). Statistically significant outcomes that directly indicated TSN effectiveness in terms of hemoglobin (1c) were found in both groups but not with regard to systolic and diastolic blood pressure. These findings also offered indirect empirical support for TSN safety. Statistically significant comparative changes in these primary indices were not observed between the groups but were suggestive of an operational calibration of TSN technology augmentation. Statistically significant changes in secondary indices were obtained in one or both groups, but not between the groups. CONCLUSIONS: The RCT’s strong behavioral basis, as well as the importance of safety and effectiveness when complex chronic illness is proximately self-managed by layperson patients, prompted the formulation of the empirical joint hypothesis that TSN would improve patient self-care while satisfying the condition of patient self-safety. Statistical and decision analysis applied to the experimental outcomes offered support for this hypothesis. Policy relevance of the research is demonstrated by the derivation of a data-grounded operational calibration of TSN technology augmentation with ready application to health care management. TRIAL REGISTRATION: ClinicalTrials.gov NCT02799953; https://clinicaltrials.gov/ct2/show/NCT02799953
format Online
Article
Text
id pubmed-7148548
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-71485482020-04-21 Improving Self-Care in Patients With Coexisting Type 2 Diabetes and Hypertension by Technological Surrogate Nursing: Randomized Controlled Trial Or, Calvin Kalun Liu, Kaifeng So, Mike K P Cheung, Bernard Yam, Loretta Y C Tiwari, Agnes Lau, Yuen Fun Emmy Lau, Tracy Hui, Pui Sze Grace Cheng, Hop Chun Tan, Joseph Cheung, Michael Tow J Med Internet Res Original Paper BACKGROUND: Technological surrogate nursing (TSN) derives from the idea that nurse-caregiver substitutes can be created by technology to support chronic disease self-care. OBJECTIVE: This paper begins by arguing that TSN is a useful and viable approach to chronic disease self-care. The analysis then focuses on the empirical research question of testing and demonstrating the effectiveness and safety of prototype TSN supplied to patients with the typical complex chronic disease of coexisting type 2 diabetes and hypertension. At the policy level, it is shown that the data allow for a calibration of TSN technology augmentation, which can be readily applied to health care management. METHODS: A 24-week, parallel-group, randomized controlled trial (RCT) was designed and implemented among diabetic and hypertensive outpatients in two Hong Kong public hospitals. Participants were randomly assigned to an intervention group, supplied with a tablet-based TSN app prototype, or to a conventional self-managing control group. Primary indices—hemoglobin A(1c), systolic blood pressure, and diastolic blood pressure—and secondary indices were measured at baseline and at 8, 12, 16, and 24 weeks after initiation, after which the data were applied to test TSN effectiveness and safety. RESULTS: A total of 299 participating patients were randomized to the intervention group (n=151) or the control group (n=148). Statistically significant outcomes that directly indicated TSN effectiveness in terms of hemoglobin (1c) were found in both groups but not with regard to systolic and diastolic blood pressure. These findings also offered indirect empirical support for TSN safety. Statistically significant comparative changes in these primary indices were not observed between the groups but were suggestive of an operational calibration of TSN technology augmentation. Statistically significant changes in secondary indices were obtained in one or both groups, but not between the groups. CONCLUSIONS: The RCT’s strong behavioral basis, as well as the importance of safety and effectiveness when complex chronic illness is proximately self-managed by layperson patients, prompted the formulation of the empirical joint hypothesis that TSN would improve patient self-care while satisfying the condition of patient self-safety. Statistical and decision analysis applied to the experimental outcomes offered support for this hypothesis. Policy relevance of the research is demonstrated by the derivation of a data-grounded operational calibration of TSN technology augmentation with ready application to health care management. TRIAL REGISTRATION: ClinicalTrials.gov NCT02799953; https://clinicaltrials.gov/ct2/show/NCT02799953 JMIR Publications 2020-03-27 /pmc/articles/PMC7148548/ /pubmed/32217498 http://dx.doi.org/10.2196/16769 Text en ©Calvin Kalun Or, Kaifeng Liu, Mike K P So, Bernard Cheung, Loretta Y C Yam, Agnes Tiwari, Yuen Fun Emmy Lau, Tracy Lau, Pui Sze Grace Hui, Hop Chun Cheng, Joseph Tan, Michael Tow Cheung. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 27.03.2020. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Or, Calvin Kalun
Liu, Kaifeng
So, Mike K P
Cheung, Bernard
Yam, Loretta Y C
Tiwari, Agnes
Lau, Yuen Fun Emmy
Lau, Tracy
Hui, Pui Sze Grace
Cheng, Hop Chun
Tan, Joseph
Cheung, Michael Tow
Improving Self-Care in Patients With Coexisting Type 2 Diabetes and Hypertension by Technological Surrogate Nursing: Randomized Controlled Trial
title Improving Self-Care in Patients With Coexisting Type 2 Diabetes and Hypertension by Technological Surrogate Nursing: Randomized Controlled Trial
title_full Improving Self-Care in Patients With Coexisting Type 2 Diabetes and Hypertension by Technological Surrogate Nursing: Randomized Controlled Trial
title_fullStr Improving Self-Care in Patients With Coexisting Type 2 Diabetes and Hypertension by Technological Surrogate Nursing: Randomized Controlled Trial
title_full_unstemmed Improving Self-Care in Patients With Coexisting Type 2 Diabetes and Hypertension by Technological Surrogate Nursing: Randomized Controlled Trial
title_short Improving Self-Care in Patients With Coexisting Type 2 Diabetes and Hypertension by Technological Surrogate Nursing: Randomized Controlled Trial
title_sort improving self-care in patients with coexisting type 2 diabetes and hypertension by technological surrogate nursing: randomized controlled trial
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148548/
https://www.ncbi.nlm.nih.gov/pubmed/32217498
http://dx.doi.org/10.2196/16769
work_keys_str_mv AT orcalvinkalun improvingselfcareinpatientswithcoexistingtype2diabetesandhypertensionbytechnologicalsurrogatenursingrandomizedcontrolledtrial
AT liukaifeng improvingselfcareinpatientswithcoexistingtype2diabetesandhypertensionbytechnologicalsurrogatenursingrandomizedcontrolledtrial
AT somikekp improvingselfcareinpatientswithcoexistingtype2diabetesandhypertensionbytechnologicalsurrogatenursingrandomizedcontrolledtrial
AT cheungbernard improvingselfcareinpatientswithcoexistingtype2diabetesandhypertensionbytechnologicalsurrogatenursingrandomizedcontrolledtrial
AT yamlorettayc improvingselfcareinpatientswithcoexistingtype2diabetesandhypertensionbytechnologicalsurrogatenursingrandomizedcontrolledtrial
AT tiwariagnes improvingselfcareinpatientswithcoexistingtype2diabetesandhypertensionbytechnologicalsurrogatenursingrandomizedcontrolledtrial
AT lauyuenfunemmy improvingselfcareinpatientswithcoexistingtype2diabetesandhypertensionbytechnologicalsurrogatenursingrandomizedcontrolledtrial
AT lautracy improvingselfcareinpatientswithcoexistingtype2diabetesandhypertensionbytechnologicalsurrogatenursingrandomizedcontrolledtrial
AT huipuiszegrace improvingselfcareinpatientswithcoexistingtype2diabetesandhypertensionbytechnologicalsurrogatenursingrandomizedcontrolledtrial
AT chenghopchun improvingselfcareinpatientswithcoexistingtype2diabetesandhypertensionbytechnologicalsurrogatenursingrandomizedcontrolledtrial
AT tanjoseph improvingselfcareinpatientswithcoexistingtype2diabetesandhypertensionbytechnologicalsurrogatenursingrandomizedcontrolledtrial
AT cheungmichaeltow improvingselfcareinpatientswithcoexistingtype2diabetesandhypertensionbytechnologicalsurrogatenursingrandomizedcontrolledtrial